1-6 of 6
Keywords: neuroinflammation
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Clin Sci (Lond) (2020) 134 (15): 2075–2090.
Published: 13 August 2020
... the activation of microglia in MPTP PD model by restoring CD200-CD200R signal inhibit microglia mediated neuroinflammation and the differentiation of T cells to Th17. Cells were stained with the following monoclonal antibodies: CD3, CD4, CD8, CD200, CD200R (Biolegend). For cytokine detection, T cells were...
Clin Sci (Lond) (2020) 134 (13): 1677.
Published: 07 July 2020
... © 2020 The Author(s). 2020 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . microglia M1/M2 sepsis neuroinflammation The authors of the original...
Clin Sci (Lond) (2020) 134 (7): 765–776.
Published: 07 April 2020
...@gmail.com ) 07 01 2020 17 03 2020 26 03 2020 27 03 2020 © 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2020 M1/M2 microglia neuroinflammation sepsis Sepsis is a life-threatening condition that is often complicated...
Clin Sci (Lond) (2020) 134 (5): 547–570.
Published: 13 March 2020
... play a role in inflammation. In this review, we try to elucidate the connections between peripheral inflammation at obesity and Type 2 diabetes and the central inflammatory process. Multiple lines of evidence highlight the importance of peripheral inflammation and its link to neuroinflammation, which...
Clin Sci (Lond) (2017) 131 (6): 425–437.
Published: 06 March 2017
... the response of stiffened blood vessels in times of increased metabolic need. Intermittent hypoxia/ischaemia activates a molecular injury cascade, producing an incomplete infarction that is most damaging to the deep WM, which is a watershed region for cerebral blood flow. Neuroinflammation caused by hypoxia...
Clin Sci (Lond) (2015) 128 (2): 95–109.
Published: 05 September 2014
..., microglia activation, spinal cord demyelination and neurological deficits suggesting the AT 2 R as potential drug target for treatment of demyelinating diseases. angiotensin type 2 receptor (AT 2 R) experimental autoimmune encephalomyelitis multiple sclerosis neuroinflammation neuroprotection new...